logo
Lab Notes: What makes Sydney's cockies so clever?

Lab Notes: What makes Sydney's cockies so clever?

Belinda Smith: First, they came for our rubbish.
News grab: Move over Ibis, there's a new bin chicken in town. The iconic Aussie bird's mostly been prying open bin lids.
Belinda Smith: And now, they're taking our water.
News grab: Sulphur crested cockatoos in Western Sydney have been observed using public drinking fountains, learning to twist the handles and drinking from the bubblers.
Belinda Smith: And it's not just one or two cockies doing this. More than 100 have been spotted drinking from bubblers. So, what do these entertaining exploits tell us about cocky innovation? And even about cocky culture? Hi, I'm Belinda Smith and you're listening to Lab Notes, the show that dissects the science behind new discoveries and current events. To explain why these birds are so bloody brainy is Lucy Aplin, a cognitive ecologist at the Australian National University. Now, I've seen children struggle to turn a water fountain tap and they have hands. Cockies have claws. So, how do they manage?
Lucy Aplin: What they have to do is they have to hold on to the stem of the fountain. So, imagine a fountain you might get in your local sports fields, very classic upright model. So, they're gripping onto the stem of the upright part with one foot and then they're turning the twist handle with their other foot. Now, the twist handle has a spring in it. So, it'll come back so that the water doesn't run forever. So, the birds actually have to put their weight down to hold that spring. And then they have to twist their head back to drink the water while keeping the weight over the handle. So, it's quite a complex action that actually involves every body part.
Belinda Smith: It's not just the strength to turn the tap but also the flexibility to kind of manoeuvre their body so that they can then enjoy the water that's coming out of the tap. Exactly, and
Lucy Aplin: the foot-mouth coordination. I always say eye-hand-eye coordination, but foot-eye coordination, foot-eye-mouth coordination in this case. So, where do these particular cockies live? So, we observed this behaviour in the Western Sydney Parklands area just near Nurragingy Reserve, which is around sort of near Doonside train station, if anyone knows Western Sydney.
Belinda Smith: In 2019, purely by chance, one of Lucy's colleagues, Barbara Klump, first spotted a thirsty cocky.
Lucy Aplin: She was walking across the sports field and she saw them doing this. And she then walked into the Nurragingy Reserve, which is next door, and asked the rangers about it. And they said, oh yeah, they do it around here all the time. They've been doing it for ages. So, I think they thought it was a, you know, this is just what the local cockies do. As many Australians will attest, they do lots of weird and wonderful things. But we were pretty excited, so we thought, right, we have to study this.
Belinda Smith: Then, not long after that initial sighting, Lucy and her team started keeping tabs on one particularly popular drinking fountain. The
Lucy Aplin: drinking fountain that was most used was the one in the sports field right next to where the sleeping trees were. So, they were using it first thing in the morning and in the afternoon. How successful are they at getting water? So, we found when we did these intensive observations at one drinking fountain, that actually only about just under 50 per cent of the attempts were successful. So, individuals could try multiple times. And sometimes the attempts were unsuccessful because they were obviously distracted by the other birds that were queuing. Maybe a more dominant bird was queuing and they were trying to keep an eye on that bird at the same time and that was influencing their success. So, they were aware that this thing could produce water and were trying and were either in the process of learning or were very successful at it already.
Belinda Smith: Ah, right. And so, did they learn from watching other cockies do it?
Lucy Aplin: That's what we assume. So, we don't think that every individual cocky innovated this behaviour or we would be equally likely to see cockatoos drinking from drinking fountains all over Australia. Everywhere there are cockatoos and drinking fountains of which there are many places with both. So, we think that the evidence we have is highly suggestive that actually it's spreading through social learning. So, one bird or maybe a couple of birds initially invented this behaviour, worked it out and then other birds observed them and adopted the behaviour and it spread through the local group to form a local tradition in this area. So,
Belinda Smith: when this behaviour was sort of first observed by your postdoc, Barbara, was this during a particularly dry
Lucy Aplin: period? No, it was actually towards the end of winter. So, it would have been in August, September because that's when we're usually doing our fieldwork. So, it wasn't particularly dry. It was something that we were a little bit surprised by for that exact reason. We thought this is a really interesting behaviour for the technical innovation part of it. It seems quite complex and it's interesting to understand how it spreads and whether it's continuing to spread. But alongside that, there's this really interesting question which is what is the adaptive benefit of it? Because we'd just come off studying another innovation which was the bin opening behaviour which we're still studying in the south of Sydney. And there, it's really obvious what the cockatoos are getting out of it. They're getting bread or pasta or pizza or all high calorie items. Delicious things. Exactly. But here, there's an artificial lake that they've made in the lovely Chinese gardens in the Nurragingy Parklands. There's a local river they could be using. There's lots of local water sources and yet they seem to be preferring to do this highly complicated behaviour where often they also have to queue for it. So, it was a bit of a mystery we also wanted to solve as to why. So, did you find out? Well, we have three working hypotheses. Unfortunately, we couldn't answer them in this study but we're hoping to get to them. So, in this study, we wanted to ask just straightforward, are they using this as a supplement to other water sources? For example, when it's really hot and dry. And we saw no evidence for that. It seemed more like they were actually preferring to use drinking fountains over those other alternative water sources. So, then we had three follow on hypotheses. Maybe the water just tastes better. And that's not, I think, out of this world because if you think about whether you would rather go down to the creek, drink slimy, silty, muddy creek water. Or whether you might prefer a nice Sydney tap water, even though some people might be rude about Sydney tap water. It's probably still preferable to muddy creek water. So, that is a possibility that they're also making that choice. The other potential explanation we thought about is whether they just feel safer drinking from drinking fountains. Because they're usually, or all of these, in this case, were in picnic areas or they're on the edge of sports fields. So, they're in open areas with really good visibility. They're off the ground. And maybe that feels much safer than going down to that waterhole where maybe the predators are lurking behind the bush.
Belinda Smith: Part of me also wonders if there's some payoff to actually working for the water. It makes me think of shelling pistachios. Somehow, the pistachio tastes much better if you're the one cracking it open. And it's like that little bit of work has just made the reward so much more tasty.
Lucy Aplin: Yes. That exact phenomenon you're describing does have a scientific name. You know, there's jargon for everything. Yes, great. It's called contra-freeloading. And it means that you'd rather work a little bit for your reward than get it for free. And it is something that has been observed in humans. And it's also been observed in captive parrots.
Belinda Smith: Okay, so we've got bin lid flipping cockies. We've got water fountain drinking cockies. What other behaviours have been reported in cockatoos?
Lucy Aplin: So one I find perhaps a little bit disturbing is that they seem to have taken a liking in some parts of Sydney to drinking discarded energy drink cans or soft drink cans. So if they find them on the ground or in the rubbish, they'll pick them up using their bill into the sort of hole, you know, the drinking hole and then tip it back to try and get the drugs.
Belinda Smith: Oh, my gosh. A caffeinated cocky. Exactly. Just what you need.
Lucy Aplin: That's why I find that one a little bit disturbing. I'm not sure what the effect of caffeine is on cockatoos, but I don't think it'd be good. And we have going along the same sort of high energy line, just like we have observations of noisy miners in Rainbow Larrakeet stealing sugar packets, cockatoos will also occasionally steal sugar packets. That's been reported to us. And another innovation which has been reported to us from the south of Sydney, from the Northern Territory, amazingly, from a little community right up in Arnhem Land and from a couple of sites up in far north of Sydney is what we're calling the lunch bag innovation. It's a bit hard to know how to label this one. It seems to involve cockatoos going to schools where the kids leave their bags outside the classroom, unzipping the bags, taking out the lunch boxes and then undoing the lunch boxes and running off with the sandwiches.
Belinda Smith: Oh, that's so cheeky. OK, so why and how can these cockies do such amazing and often annoying things?
Lucy Aplin: There's a few hypotheses that have been put forward. When we look at overall brain size across parrots, it seems like one thing that fits really well is what we call the cognitive buffer hypothesis. And it's this idea that if you live a long time, which parrots do, your environment's going to be changing around you, unless you're in a really stable environment. But parrots are often not in a really stable environment. The environment's changing and having a large brain allows them to cope with that change that they might experience during their life. So it provides a buffer to the sort of swings and arrows of fortune by allowing you to work out solutions to changes. And that sort of explanation for the evolution of intelligence in parrots, it's not the only one, but that hypothesis fits really nicely with the urban adaptability that we see because urban environments are that. They're changing, novel environments where things can change. They can be pretty stable, but then they can change really rapidly when the local government decides to change all of the drinking fountains or whatever. So having a big brain might allow you to cope with that by learning new solutions and adjusting your behaviour.
Belinda Smith: Wow. Just like us humans then. And cockies don't just have big brains. They also have a lot of cells or neurons in those brains.
Lucy Aplin: So a cockatoo has about the same total number of neurons. So just straight count, not accounting for differences in body size or anything, just straight count. The same total number of neurons or similar to a macaque monkey, which is a medium sized monkey. Wow. So they're really punching above their weight. Like literally?
Belinda Smith: Yes. These behaviours, they're kind of quirky and fun and maybe a bit messy, but they're very interesting. But what does this tell us about cocky culture?
Lucy Aplin: Well, it tells us that they're very capable of learning from each other, from social learning. We have no evidence for teaching, so they're not doing that. Watch out if they start. No evidence for that. But they are very capable of observing other individuals and adopting the behaviour if it's beneficial. And they're capable of transmitting that behaviour over quite large geographic areas. Some of the studies we're doing now, they're not published yet, so I don't have the full set of results. But our preliminary results from experimental work is showing that actually new beneficial behaviours can spread over, say, the entire city of Canberra within just a couple of weeks. So the way their society is organised is really promotes that rapid spread and population level adoption of new behaviours. So I think that tells us something about the secret to their success and something about their life history in general. These are the elephants of the bird world. They're really long-lived, they're really brainy, and they're really social. And so they have a society that we recognise and we can also understand. We can look at what they're doing and understand it better than with some other species.
Belinda Smith: That was Lucy Aplin, a cognitive ecologist at the Australian National University. She and her colleagues published their study about the water fountain drinking cockies in the Royal Society Biology Letters last week. And thanks for listening to Lab Notes on ABC Radio National, where every week we dissect the science behind new discoveries and current events. I'm Belinda Smith. This episode was produced on the lands of the Wurundjeri and Menang Noongar people. Fiona Pepper's the producer and it was mixed by Angie Grant. We'll catch you next week.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Complete collapse': Bombshell report into AI accuracy indicates your job is probably safe
‘Complete collapse': Bombshell report into AI accuracy indicates your job is probably safe

News.com.au

time6 hours ago

  • News.com.au

‘Complete collapse': Bombshell report into AI accuracy indicates your job is probably safe

The latest form of cutting-edge artificial intelligence technology suffers 'fundamental limitations' that result in a 'complete accuracy collapse', a bombshell report from Apple has revealed. Researchers from the tech giant have published a paper with their findings, which cast doubt on the true potential of AI as billions of dollars are poured into developing and rolling out new systems. The team put large reasoning models, an advanced version of AI, used in platforms like DeepSeek and Claude, through a series of puzzle challenges ranging from simple to complex. They also tested large language models, which platforms like ChatGPT are built on. Large language model AI systems fared better than large reasoning models with fairly standard tasks, but both fell flat when confronting more complex challenges, the paper revealed. Researchers also found that large reasoning models began 'reducing their reasoning effort' as they struggled to perform, which was 'particularly concerning'. 'Upon approaching a critical threshold – which closely corresponds to their accuracy collapse point – models counterintuitively begin to reduce their reasoning effort despite increasing problem difficulty,' the paper read. The advancement of AI, based on current approaches, might've reached its limit for now, the findings suggested. Niusha Shafiabady, an associate professor of computational intelligence at Australian Catholic University and director of the Women in AI for Social Good lab, said 'expecting AI to be a magic wand' is a mistake. 'I have been talking about the realistic expectations about the AI models since 2024,' Dr Shafiabady said. 'When AI models face countless interactions with the world, it is not possible to investigate and control every single problem that could happen. That is why things could get out of hand or out of control.' Gary Marcus, a leading voice on AI and six-time author, delivered a savage analysis of the Apple paper on his popular Substack, describing it as 'pretty devastating'. 'Anybody who thinks [large language models] are a direct route to the [artificial generative intelligence] that could fundamentally transform society for the good is kidding themselves,' Dr Marcus wrote. Dr Marcus then took to X to declare that the hype around AI has become 'a giant game of bait and switch'. 'The bait: we are going to make an AI that can solve any problem an expert human could solve. It's gonna transform the whole world,' Dr Marcus wrote. 'The switch: what we have actually made is fun and kind of amazing in its own way but rarely reliable and often makes mistakes – but ordinary people makes mistakes too.' In the wake of the paper's release, Dr Marcus has re-shared passionate defences of AI shared to X by evangelists defending the accuracy flaws that have been exposed. 'Imagine if calculator designers made a calculator that worked 80 per cent correctly and said 'naah, it's fine, people make mistakes too',' Mr Marcus quipped. Questions about the quality of large language and large reasoning models aren't new. For example, when released in April, OpenAI described its new o3 and o4-mini models as its 'smartest and most capable' yet, trained to 'think for longer before responding'. 'The combined power of state-of-the-art reasoning with full tool access translates into significantly stronger performance across academic benchmarks and real-world tasks, setting a new standard in both intelligence and usefulness,' the company's announcement read. But testing by prestigious American university MIT revealed the o3 model was incorrect 51 per cent of the time, while o4-mini performed even worse with an error rate of 79 per cent. Truth and accuracy undermined Apple recently suspended its news alert feature on iPhones, powered by AI, after users reported significant accuracy errors. Among the jaw-dropping mistakes was an alert that tennis icon Rafael Nadal had come out as gay, alleged United Healthcare CEO shooter Luigi Mangione had died by suicide in prison, and a winner had been crowned at the World Darts Championship hours before competition began. Research conducted by the BBC found a litany of errors across other AI assistants providing information about news events, including Google's Gemini, OpenAI's ChatGPT and Microsoft's CoPilot. It found 51 per cent of all AI-generated answers to queries about the news had 'significant issues' of some form. When looking at how its own news coverage was being manipulated, the BBC found 19 per cent of answers citing its content were factually incorrect. And in 13 per cent of cases, quotes said to be contained within BBC stories had either been altered or entirely fabricated. Meanwhile, a newspaper in Chicago was left red-faced recently after it published a summer reading list featuring multiple books that don't exist, thanks to the story copy being produced by AI. And last year, hundreds of people who lined the streets of Dublin were disappointed when it turned out the Halloween parade advertised on an events website had been invented. Google was among the first of the tech giants to roll out AI, summarising search results relying on a large language model – with some hilarious and possibly dangerous results. Among them were suggestions to add glue to pizza, eat a rock a day to maintain health, take a bath with a toaster to cope with stress, drink two litres of urine to help pass kidney stones and chew tobacco to reduce the risk of cancer. Jobs might be safe – for now Ongoing issues with accuracy might have some companies thinking twice about going all-in on AI when it comes to substituting their workforces. So too might some recent examples of the pitfalls of people being replaced with computers. Buy now, pay later platform Klarna shed more than 1000 people from its global workforce as part of a dramatic shift to AI resourcing, sparked by its partnership with OpenAI, forged in 2023. But last month, the Swedish firm conceded its strong reliance on AI customer service chatbots – which saw its employee count almost halved in two years – had created quality issues and led to a slump in customer satisfaction. Realising most customers prefer interacting with a human, Klarna has begun hiring back actual workers. Software company Anysphere faced a customer backlash in April when its AI-powered support chatbot went rogue, kicking users out of the code-editing platform Cursor and delivering incorrect information. It then seemingly 'created' a new user policy out of thin air to justify the logouts – that the platform couldn't be used across multiple computers. Cursor saw a flood of customer cancellations as a result. AI adviser and former Google chief decision scientist Casse Kozyrkov took to LinkedIn to share her thoughts on the saga, dubbing it a 'viral hot mess'. 'It failed to tell users that its customer support 'person' Sam is actually a hallucinating bot,' Ms Kozyrkov wrote. 'It's only going to get worse with AI agents.' Many companies pushing AI insist the technology is improving swiftly, but a host of experts aren't convinced its hype matches its ability. Earlier this year, the Association for the Advancement of Artificial Intelligence surveyed two dozen AI specialists and some 400 of the group's members and found a surprising level of pessimism about the potential of the technology. Sixty per cent of those probed don't believe problems with factuality and trustworthiness 'would soon be solved', it found. Issues of accuracy and reliability are important, not just for growing public trust in AI, but for preventing unintended consequences in the future, AAAI president Francesca Rossi wrote in a report about the survey. 'We all need to work together to advance AI in a responsible way, to make sure that technological progress supports the progress of humanity and is aligned to human values,' Ms Rossi said. Projects stalled or abandoned Embarrassing and potentially costly issues like these are contributing to a backtrack, with analysis by S&P Global Market Intelligence showing the share of American and European companies abandoning their AI initiatives rising to 42 per cent this year from 17 per cent in 2024. And a study released last month by consulting firm Roland Berger found a mammoth investment in AI technology wasn't translating to useful outcomes for many businesses. Spending on AI by corporates in Europe hit an estimated US$14 billion (AU$21.4 billion) in 2024, but just 27 per cent were able to fully integrate the technology into their operations or workflows, the research revealed. 'Asked about the key challenges involved in implementing AI projects, 28 per cent of respondents cited issues with data, 25 per cent referenced the complexity of integrating AI use cases, and 15 per cent mentioned the difficulty of finding enough AI and data experts,' the study found. Those findings were mirrored in an IBM survey, which found one-in-four AI projects delivered the returns they promised. Dr Shafiabady said there are a few reasons for problems facing AI, like those identified in Apple's research. 'When dealing with highly complex problems, these types of complex AI models can't give an accurate solution. One of the reasons why is the innate nature of algorithms,' Dr Shafiabady said. 'Models are built on mathematical computational iterative algorithms that are coded into computers to be processed. When tasks get very complicated, these algorithms won't necessarily follow the logical reasoning and will lose track of them. 'Sometimes when the problem gets harder, all the computing power and time in the world won't enhance AI model's performance. Sometimes when it hits very difficult tasks, it fails because it has learnt the example rather than the hidden patterns in the data. 'And sometimes the problem gets complicated, and a lot of computation resource and time is wasted over exploring the wrong solutions and there is not enough 'energy' left to reach the right solution.'

'Best before' and 'use-by' dates could cost Australian families $2,500 a year
'Best before' and 'use-by' dates could cost Australian families $2,500 a year

ABC News

time7 hours ago

  • ABC News

'Best before' and 'use-by' dates could cost Australian families $2,500 a year

Australians are frequently throwing out perfectly good food because of unclear labelling leading to food waste that could cost the average household about $2,500 a year, a new report says. The research was conducted in workshops by RMIT University and End Food Waste Australia, and aimed to find how labelling and storage advice on products could be made clearer, to avoid people throwing out food before it goes bad. Foodbank Australia estimates Australians throw away about 7.6 million tonnes in Australia each year, which equates to about 312 kilograms of food wasted per person. The Department of Climate Change, Energy, the Environment and Water said the waste equated cost the Australian economy about $36.6 billion a year, which is about $2,500 per household. RMIT's associate professor and lead author Lukas Parker said the labelling system in Australia needed a lot of work. "Nobody wants to throw away good food," he said. "It's bad for their hip pocket, and most people can see that it's not a good thing to throw away food. "We've done previous studies with the one preceding this one, where we interviewed a whole bunch of people about use by dates and best before labels, and one of the things that came out of that was that consumers said that they wanted what was best for their families. Dr Parker said the work, which has not been peer-reviewed, examined how to help people with poor eyesight or English as a second language understand food labelling. "When we interview anybody, the first thing that people say is, 'I don't waste food,'" he said. "But the reality is that we know that [we waste] around 2 kilograms per person per week in Australia." The researchers set up workshops with a different mix of academics, designers, retailers, food producers, policymakers and consumers. They looked at food labels that had been developed by researchers, which were different from the average best before date — including additional text cues like 'do not eat after this date', or changing colour and adding QR codes for more information. The groups provided feedback on food labelling and what needed to improve, and what could hurt their implementation. They then assessed the labels on what they thought would best address food waste: consumer-centric change, policy-led change and stakeholder-driven change. Both groups preferred clear, concise and visually distinct date labels and storage advice, but there were some differences in what they prioritised. The stakeholders — manufacturers and retailers — were more concerned about food safety, compliance and cost of change. Consumers were more interested in how the label worked, food quality and waste reduction. For example, consumers said they often associated QR codes with marketing and did not often use them. However, stakeholders said they were helpful to provide more information, without sacrificing 'real estate' on the current food label. "The industry players tended to view household food waste as a consumer responsibility, reflected by their focus on consumer education campaigns rather than addressing systemic factors within their own industry," the report said. Researchers said households were responsible for 40 per cent of Australia's total food waste. The report also found if there was any change to food labelling, the cost would likely be passed on to the consumer. "The industry players were hesitant to lead efforts to address consumer confusion with date labels and storage advice, as they see no market advantage," it said. Dr Parker said the research would inform the next phase of the National Date Labelling and Storage Advice Project, which will bring together supermarkets, food brands and government to co-design, test and roll out a national framework for food labelling. "What we have found is that industry are interested," he said. "They can see this is coming down the line, but they are actually looking for some coordination and direction, and that's where we're hoping that we will be able to be part of that process. "It's not easy; we've got two big supermarkets, and unless you have buy-in from both of those … it's very difficult to get something in. "But we've seen it with other different types of strategies slowly coming on board, like the recycling logo. "It can happen, it just it takes a lot of time." The work has been supported by the End Food Waste Cooperative Research Centre, whose activities are funded by the Australian government's Cooperative Research Centre Program. The National Date Labelling and Storage Advice Project is also funded through the Queensland government's Recycling and Jobs Fund, Green Industries South Australia, New South Wales Environment Protection Authority, and Sustainability Victoria.

Diagnosing scabies in the Pacific could get easier and faster, saving lives
Diagnosing scabies in the Pacific could get easier and faster, saving lives

ABC News

time7 hours ago

  • ABC News

Diagnosing scabies in the Pacific could get easier and faster, saving lives

ABC: podcast. You're listening to Pacific Pulse on ABC Radio Australia. Matthew Paxman: Part of the issue with scabies is you get these tiny little skin lesions and also through all the extra scratching your skin's inflamed. So you can get bacterial infections through the skin. Melissa Maykin: Have you ever had to scrub and lather to get rid of those relentless little mites called scabies? Australian scientists are now developing a world first rapid test that can spot scabies in just 10 to 20 minutes, no lab needed, and it even detects common bacterial skin infections. Scabies is a huge public health headache across the Pacific, with around 18 to 20% of people in Fiji, Solomon Islands and other places affected, especially children. For those who can't get rid of the mites, scabies can link to serious complications like secondary infections, heart and kidney disease. Thanks to Melbourne, Australia's Zip Diagnostics and trials held in Darwin, this portable battery powered test could revolutionise how remote communities fight this itchy, neglected tropical disease. To dive into the science, I'm speaking to the company's Scientific Director, Associate Professor Jack Richards, and the company's PhD Research Assistant, Matthew Paxman. Associate Professor Jack Richards: Look, it's an interesting disease in many regards. And so it's been of interest to us, firstly because it's actually a really common disease. It's all throughout the world, and estimates are in the range of 200 to even 500 million cases per year of this disease globally. So it's a very common disease. It's highly prevalent through the Pacific. So some of the countries that have the highest rates of this in the world are in the Pacific. So I think Fijian Vanuatu was recently identified as in the top five countries of the world. It has a huge impact on the quality of life for people. It's actually caused by a mite, a little insect that actually burrows into the skin. And actually, these burrows cause an inflammatory and allergic response and intense itching. So people that get these infections with scabies mites have a huge impact on their life because they're constantly itching, this through the day and the night, and it's unrelenting. That's sort of the impact of it. And then they also are highly at risk of getting secondary bacterial infections, which can be either localised in those same areas because of all the scratching, or they can actually spread and cause bloodstream infections and septicemia, and even special infections of the heart called rheumatic heart disease. From seemingly innocuous little insect that lives on the skin and burrows in the skin, you've got this huge impact globally on health and just the way of life of people. So we think that's a really important issue to deal with. It's what we call a neglected tropical disease because most people in the world are not interested in really dealing with it or don't have the resources to look at this disease because it really occurs in areas of remote communities and low to middle income countries. The people that suffer the most are the poorest people in the world and often don't have the resources and access to health services. Despite being really common and having a huge impact on their life, not many people are helping to address this issue. Yeah, that's sort of part of the reason. And the other one is really that the diagnostics themselves are very poor. Generally speaking, the current approach to this is that healthcare professionals have a look at somebody's skin and they usually make their best guess of whether this is scabies or not. And in some cases, if they've got access to a laboratory or a microscope, they might send off some skin scrapings and try and identify this scabies insect under the microscope. So we think we can offer something to that. Melissa Maykin: Yeah, that's really another side of this whole issue. So what you talked about having secondary illnesses as a result of the scabies, are you able just to explain quickly what happens in the body due to that infection and the kind of secondary issues that can arise? Associate Professor Jack Richards: Yeah, sure. Matt, do you want to? Matthew Paxman: Yeah. So part of the issue with scabies is you get these tiny little skin lesions and also through all the extra scratching, your skin's inflamed. So you can get bacterial infections through the skin from that. So particularly group A strep and staphylococcus aureus, these two bacteria that can grow and cause infections on the skin. So that potentially could cause more severe types of skin lesions, but sometimes they can go deeper into the tissue, into the bloodstream and cause some severe complications like rheumatic fever, rheumatic heart disease, Jack said before. And you get issues such as sepsis and toxic shock, but these conditions are potentially life threatening. So it's really important to control scabies to make sure these bacterias are getting through. The skin needs to stay intact to keep these bacteria that is sometimes commensally on the skin outside of your internal system. Melissa Maykin: Mm. No, thank you for that. It's really good to keep it at layman's level for not just myself, but for anyone who's really not too aware of the kind of health science behind scabies. But I was always of the belief that scabies was contracted from animals. So what carries scabies? Where does it mostly spread from? Matthew Paxman: So animals are affected by scabies as well, but humans won't generally get scabies from an animal. Scabies transmits through skin to skin contact with another infested person. And sometimes the scabies can actually survive on materials like the bed sheets or fabrics. So you need to have your skin exposed to a fertilized mite to contract scabies from another human. So that's why overcrowding is a major risk factor for this disease. Not necessarily hygiene, it's just that close skin to skin contact that causes these high level of transmission in overcrowded regions. Melissa Maykin: Thank you. So just jumping forward to the diagnostic test, are you able to just explain how this tool works? Matthew Paxman: Yeah, so we're looking at molecular diagnostics. So the difference with molecular diagnostics compared to the current diagnostic methods for scabies is we're trying to detect the genetic material of the mites or the particles that they leave behind on the body. So the previous methods, as we mentioned, involves trying to look at the skin and see evidence of mites or eggs. But with the molecular test, it would be a standardized sampling method. Essentially what we're doing is we're adopting the LAMP technique, which is a nucleic acid amplification system called loop-mediated isothermal amplification. So in concept, it's similar to PCR, but it tends to be faster and more specific. And the big benefit of LAMP is you can run it at one single temperature. So that means the instruments that it can run on can be simpler, more portable, and able to be implemented into these resource limited settings that we're really interested in. So that's what we're doing at the moment is we're designing the LAMP assay. So all the constituents that go into it. And then another important aspect is we're trying to design a simplified sample preparation workflow that so any untrained users, healthcare workers, will be able to easily process and run the tests. Melissa Maykin: Yeah, fantastic. I can't really visualize it at the moment, but what does it look like? Yeah, if you're standing in the lab, you're about to run some tests on the scabies. Matthew Paxman: I can, I have some things right next to me. This might not be that relevant for radio, but this is instruments. So at Zip Diagnostics, we have a point of care diagnostic platform called the P2. So it's this instrument here. It's got a touchscreen that provides all the prompts to do the steps. And essentially, our tests are these little lyophilized cartridges. So that's got the LAMP assay in there. And you're going to be able to process the sample on this deck and set up the test and run it within this little light, small, portable instrument. This is a platform approved by the TGA. So we can use it for clinical purposes here in Australia and can probably talk about elsewhere. Yeah, Associate Professor Jack Richards: and Matt's raised some really important points there. Where this disease occurs is in these remote settings in most cases, and they can be really far away from laboratory services. And so it's really important that we take the test to the people that have it. And what Matt's showing us here is a test, which is small, it's very portable, can run off a battery. And it really makes use of the best technology that we've got in the world to detect the DNA of these organisms. So it's a highly sensitive test. And yeah, and it's got to be highly usable for the people that are going to operate this in these environments. And so it's got to be a simple test to run. And it's also got to have components to the test which don't require cold chain supply. So it's no good being in these environments where there's no refrigeration or freezing access. So we have these freeze dried components to the assay which allow it to be then deployed and stored out in those environments. You're ABC: listening to Pacific Pulse on ABC Radio Australia. Melissa Maykin: On the show today, you're hearing from Dr. Jack Richards from Zip Diagnostics and PhD researcher and research assistant, Matthew Paxman. We're talking about a groundbreaking new SCABES test. In 2022, Solomon Islands became the first country to distribute ivermectin to its entire population to tackle SCABES, a disease that affects one in four people there and is linked to serious infections like blood poisoning and kidney disease. The ABC's Jordan Fennell had this report. Prianka Srinivasan ABC: Solomon Islands has become the first country in the world to have the anti-parasitic drug ivermectin distributed to its entire population to treat SCABES. The drug attracted controversy during the pandemic after it was linked to coronavirus misinformation. But as Jordan Fennell reports, health experts are optimistic about the success of the rollout. Jordan Fennell: In a clinic in Honiara, patients are furiously scratching themselves. Oliver Sokana: SCABES is quite distemping in any way we try to describe it. But they will spend time in itching and scratching the body and try to get themselves to feel comfortable. It's really distemping. Jordan Fennell: Oliver Sakana from the Solomon Islands Ministry of Health is overseeing the rollout of ivermectin to treat SCABES. He estimates they're helping more than 200 people a day. Oliver Sokana: That means we already treated more than 5,000 people in provinces that they already started. Jordan Fennell: In a country with a population of more than 680,000 people, one in four suffer from the skin disease. But relief from the pain will come quickly. Just two doses of ivermectin over the space of a week will get rid of SCABES. Sarah Anderson: Ivermectin is an antiparasitic drug and SCABES is a parasite. And so the ivermectin works to actually kill the little SCABE mite that has dug under the skin and made its home in somebody's skin. Sarah Jordan Fennell: Anderson is the Murdoch Children's Research Institute's World SCABES Program Manager. She says it's not just a disease that makes you itchy. If left untreated, it can lead to serious consequences. Sarah Anderson: So it can lead to very serious skin infections. As kids start scratching the SCABES, the skin breaks and then infection can get into the skin. And then that has been shown to be able to lead to very serious bacterial skin infections, but also to blood infections. And there's also a connection to kidney disease and heart disease. Jordan Fennell: During the start of the COVID-19 pandemic, ivermectin became a controversial drug when former US President Donald Trump urged people to use it to treat coronavirus, but doctors were advising against it. Ms Anderson says while it might not be effective to deal with COVID, for years it has worked to treat antiparasitic diseases like SCABES. Sarah Anderson: Ivermectin for the use of SCABES and other parasites has long been researched and shown to be effective in very, very good trials. Jordan Fennell: She says this distribution project in Solomon Islands is the result of more than 10 years of research and aims to give everyone in the country a treatment of ivermectin to stop the transmission over the next few months. Oliver Sukarna says his team of thousands are working hard to deliver the medicine. We Oliver Sokana: have the evidence. We have the evidence that SCABES is really a public health problem in Solomon Islands. So this MDA rollout is very significant in the control of SCABES in this country. Jordan Fennell: A similar rollout will go ahead in Fiji in September, and if they're able to get more funding, Ms Anderson hopes to take the life-changing treatment to more Pacific countries. Sarah Anderson: SCABES tends to be kind of like the disease that doesn't get a lot of attention. It definitely is an area where we would love to see more people joining this sort of mission to get rid of SCABES. Melissa Maykin: And that's what we're talking about today. That was Sarah Anderson, Murdoch Children's Research Institute World SCABES Program Manager, ending that report by Jordan Fennell for Pacific Beat. But a new diagnostic tool to detect SCABES early is in the works and could be a game changer for Pacific nations and their communities. Here's Zip Diagnostics Associate Professor Jack Richards. Associate Professor Jack Richards: So it's not as simple as just making a widget that just gets thrown at people. What we really want to do is work with communities and work with local experts and stakeholders just to really understand the setting and the need that they've got and the capability that they've got. We want to design this to be a test that's really suitable for them in those environments. So we're just beginning that process now. We're working with a great team up at Menzies who do a lot of work with First Nations communities up in the top end of Australia and beginning to liaise with people across the Pacific. We've done lots of work with PNG in the past and Fiji and Vanuatu. And so we're going to really continue that work to make sure that this test is actually designed and is appropriate for use in those settings. And I think a diagnosis does several things. One is, at the moment, you've got this situation between a patient and a healthcare professional where both of them are trying to make their best guess. Is this scabies or is it something else? Is it a mosquito bite or is it an allergic reaction eczema or something like that? And it creates a really difficult dynamic in the clinical decision making process because there's uncertainty. So one of the aspects of bringing a test like this in is we want data driven clinical decision making and that's a process that occurs between the patient and the healthcare professional. So the patient gets better data and is a participant in a point of care setting of their own clinical management and having access to data that confirms the diagnosis really provides them an incentive to get on with treatment and to complete treatment. And that's actually really important and it's particularly important for scabies. The treatment usually takes the form of a cream, as you mentioned, and that cream is an anti insecticide sort of cream that's applied usually from the neck down to the feet. So it's actually quite a tricky one to apply. Melissa Maykin: It is, yeah. Associate Professor Jack Richards: It's not that fun. You've got to douse yourself literally from head to toe in this cream and usually sit it out for overnight generally and then get up in the morning and wash it all off again. That's the most common form of treatment and usually you've got to back that up with a second round of that treatment one to two weeks later. There is a form of treatment that you can use, which is a tablet, but that's not always available in some of these settings. That's a little bit easier to administer, but it again also requires a sort of follow up dose. So you can see for both of these, having knowledge that this is the disease that you've got and therefore the need to do this sort of treatment because it is laborious can actually really help with doing that treatment course properly. Melissa Maykin: Yeah. Save a lot of people's time and resources going straight to what they know is needed to be done. And yeah, my friend did have to douse herself in the cream. The most tedious part was when she missed a spot and then the scabies didn't go away. So she had to just keep doing it on repeat until she hits. It took months. I was really shocked by how difficult it was for her to get rid of it. And I guess there's also that social stigma too, of feeling quite dirty and quite infested with a disease. There's layers to the feeling of contracting something like that. This I'm sure is going to make a big difference for people to get on top of it really quickly. But maybe Matt, if you can answer this, what other types of common skin infections has this also helped detect? Matthew Paxman: So for our test, we're also going to be designing targets that will detect the two main bacterial infections that often go along with scabies. So that's group A strep and Staph aureus. These are bacteria that commonly are pathogenic to humans, but sometimes they just live on the skin and not cause issues. But then with the scabies, you get the lesions and they can enter your system and cause some severe diseases. So it will be the same sample. So you will only have to take samples or inspect the patient once. A lot of the other diagnostic methods sometimes overlook bacterial infections because if your patient comes in and they're complaining about severe itching, they might not be looking for bacterial infections. So it's really important to be able to diagnose those because they require a different treatment than scabies. So in scabies, you'll need antimicrobial sort of medicines or creams in that case. Melissa Maykin: And a little side to this, I was talking to Dr. Mark Jacobs, World Health Organization, maybe last year about the rise of antimicrobial resistance. It's especially an issue, I guess, in the region, in the Pacific, where antibiotics is scarce. The right antibiotics isn't often administered. Are you working around antibiotics in this way? And is this something that you have to be aware of? Associate Professor Jack Richards: Yeah, it's a really important issue and it's becoming increasingly problematic globally. And it's driven by lots of different factors. But one of the factors is, as you're saying, the lack of diagnostics to really guide, do we need antibiotics in this instance or not? Are we making the right decision to give this patient antibiotics? And more particularly, are we giving the right antibiotics when we do that? And obviously, the best information we can have is, yes, there's this infection here and it is susceptible to this particular antibiotic. So we've even chosen the right antibiotic for this particular bug. So they're the sort of aspirations that we have. And part of that will be part of this test as we develop it. Melissa Maykin: Yeah, great. What happens next now that you've developed this test? Where are things at for you guys? Associate Professor Jack Richards: It's still under development. So it's in the early phases of the development. So Matt is doing the design of that at the moment and making good progress. So we're about to start doing some initial clinical studies with the collaborators that we've got at the Menzies in Darwin so that we can really start to understand if this test is working properly. And then we, as an Australian company, the first Australian company to ever get a point of care molecular test approved by the TGA. So we're going to use all of those learnings and that effort that we put into making this test in Australia. So we're really proud of being able to do that and have Australian made products like this that hopefully are globally important products. And so, yeah, keep people up to date over the next year or two as this goes through the formal clinical studies and the regulatory approval processes. It's a fair journey, obviously, to get these things into use for humans. Melissa Maykin: Yeah, absolutely. Yeah, Matt, was there anything, did you have any comment about how you guys are tracking? Matthew Paxman: Not too much extra than what Jack said. Melissa Maykin: Yeah, that's okay. I just might ask you, Matthew, because this is a PhD area of yours, if I can ask, I guess what fascinates you most about this area? I think you contribute hugely to communities that are very much in need. But yeah, you're able to share just finally a little bit about what drives your motivation in this area of research. Matthew Paxman: So my original study, I was trained as like a biochemist and working at Zip Diagnostics, I've got involved with looking at infectious diseases and different pathogens. And that's really fascinated me. And one area that I was excited about was having a look at different bacterial infections. And then I was pretty naive to scabies before this project started, which makes sense. It's a neglected disease. People in these remote communities know about it, but in other areas, it's not very widely discussed. So it was really interesting, a really interesting disease and really important with this like hidden, massive global prevalence. So I thought it was really important. And I also very much appreciate how important these issues are to regions such as like Indigenous Australian populations and other sort of low middle income areas like the Pacific Islands and certain areas in Africa. So that really fascinates me. Melissa Maykin: A really big thank you to Associate Professor Jack Richards, the Scientific Director of Zip Diagnostics and Research Assistant and PhD candidate Matthew Paxman for their time on the show today. This has been Pacific Pulse with me, Melissa Makin. If you missed any part of this episode and you'd like to listen back, you can search for us on the ABC Pacific website at Pacific Pulse or find us on your favorite streaming platform. If you'd like to hear more conversations about health care in the Pacific, consider listening to the latest episode of PoliTalk with Scott Widear. Basic medications like paracetamol and antibiotics are very hard to come by in many Pacific countries at the moment, and this is leaving doctors and patients struggling under the strain of sickness. You can find them by searching for PoliTalk, P-O-L-I-T-O-K on the ABC Pacific website. This episode was produced on the lands of the Jagera and the Turrbal people.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store